Safety of LBH589 Alone and in Combination With Intravenous Docetaxel and Prednisone
Clinical trial NCT00419536 · TERMINATED
Trial details
- NCT number
- NCT00419536
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.